Encompass Health (NYSE: EHC) director gets dividend-linked RSUs

Rhea-AI Filing Summary

Encompass Health Corp director Kevin J. O'Connor reported a small dividend-related equity grant. On January 15, 2026, he acquired 17 shares of Encompass Health common stock at a reported price of $0, bringing his directly held stake to 9,912 shares. According to the award terms, this reflects restricted stock units credited to non-employee directors in connection with common stock dividend payments. For this dividend, Encompass Health paid $0.19 per share, and the closing stock price on the payment date was $102.80, which was used to calculate the number of RSUs credited.

Insider Trade Summary

Net Buyer: 17 shares

Net Buy 1 txn

Insider O'Connor Kevin J.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	17	$0.00	$0.00

Holdings After Transaction: Encompass Health Common Stock — 9,912 shares (Direct)

Footnotes (1)

1. F1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $102.80. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/16/2026 - 04:23 PM Learn about SEC filing dates

FAQ

What insider transaction did Encompass Health (EHC) report for Kevin J. O'Connor?

Encompass Health reported that director Kevin J. O'Connor acquired 17 shares of Encompass Health common stock on January 15, 2026 at a reported price of $0 per share, increasing his directly held position to 9,912 shares.

Why did Kevin J. O'Connor receive 17 additional shares of Encompass Health (EHC)?

The 17 additional shares reflect restricted stock units (RSUs) credited under outstanding RSU award agreements for non-employee directors. These RSUs are credited in connection with common stock dividend payments.

How are dividend-related RSUs calculated for Encompass Health (EHC) directors?

The number of RSUs credited equals (RSUs in the director's account on the dividend record date × per-share dividend) ÷ the closing price on the dividend payment date, as described in the award agreements.

What dividend and stock price were used for the January 15, 2026 Encompass Health (EHC) RSU credit?

On January 15, 2026, Encompass Health paid a common stock dividend of $0.19 per share, and the closing stock price that day was $102.80, which was used to calculate the RSUs credited.

Does the Form 4 show any derivative security transactions for Encompass Health (EHC)?

The Form 4 excerpt lists no derivative security transactions in Table II. The only reported transaction is the acquisition of 17 shares of Encompass Health common stock linked to dividend-related RSUs.

What is Kevin J. O'Connor’s role at Encompass Health (EHC) in this Form 4?

In this filing, Kevin J. O'Connor is identified as a director of Encompass Health Corp and is not listed as an officer or 10% owner.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Connor Kevin J.

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	01/15/2026		A		17(1)	A	$0	9,912	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $102.80. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Kevin J. O'Connor	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.